TREATMENT AND POST-TREATMENT EFFECTS OF CHEWABLE FLUORIDE TABLETS ON DENTAL-CARIES AFTER 9 AND 1/2 YEARS - FINAL REPORT

被引：0
|
作者：
DRISCOLL, WS [1 ]
HEIFETZ, SB [1 ]
BRUNELLE, JA [1 ]
机构：
[1] NIDR,NATL CARIES PROGRAM,BETHESDA,MD 20014
来源：
JOURNAL OF DENTAL RESEARCH | 1980年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R78 [口腔科学];
学科分类号：
1003 ;
摘要：
引用
收藏
页码：406 / 406
页数：1
相关论文
共 41 条
  • [41] Adaptive Design Single Center Phosphodiesterase Type 4 (PDE4) Inhibitor - Ibudilast (MN-166-ALS-1201) Phase 1b / 2a Clinical Trial Double - Blind (DB) with Open Label Extension (OLE) [NCT02238626] for Amyotrophic Lateral Sclerosis (ALS) Patients [1] Not Requiring Non-Invasive Ventilation (no NIV) up to 5 years (Early Cohort - EC) and [2] Requiring Non-Invasive Ventilation (NIV) up to 10 years (Advanced NIV Cohort - ANC) from Disease Onset - Report of Clinical Trial DB, OLE and Post-Treatment Cessation Epochs - Per-Protocol (PP) Treatment Completion Associated with Improved Survival and Post Treatment Cessation Loss of Muscle Strength
    Brooks, Benjamin Rix
    Bravver, Elena
    Sanjak, Mohammed
    Langford, Velma
    Moore, Linda
    Smith, Nicole
    Lucas, Nicole
    Nichols, Mindy
    Lary, Cynthia
    Newell-Sturdivant, Allison
    Nemeth, Joanne
    Russo, Priscilla
    Brandon, Nicol
    Ranzinger, Lisa
    Burdette, Maryanne
    Wright, Kathryn
    Ward, Amber
    Holsten, Scott
    Fischer, Michael
    Hillberry, Rachel
    Bockenek, William
    Lindblom, Scott S.
    Bringardner, Benjamin
    Sachar, David
    Dojillo, Joanna
    Matsuda, Kazuko
    Iwaki, Yuichi
    NEUROLOGY, 2017, 88
12345